(Q38366860)

English

A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 September 2017

0 references

1 reference

Europe PubMed Central

A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. (English)

1 reference

Europe PubMed Central

2 September 2017

0 references

inflammatory bowel diseases

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Stacy B Menees

1

1 reference

Europe PubMed Central

2 September 2017

Corey Powell

2

1 reference

Europe PubMed Central

2 September 2017

Jacob Kurlander

3

1 reference

Europe PubMed Central

2 September 2017

Akash Goel

4

1 reference

Europe PubMed Central

2 September 2017

William D Chey

5

1 reference

Europe PubMed Central

2 September 2017

language of work or name

0 references

publication date

3 March 2015

1 reference

Europe PubMed Central

2 September 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

2 September 2017

110

1 reference

Europe PubMed Central

2 September 2017

3

1 reference

Europe PubMed Central

2 September 2017

444-454

1 reference

Europe PubMed Central

2 September 2017

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

AGA technical review on irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

The burden of selected digestive diseases in the United States.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

An evidence-based position statement on the management of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Identification of a prodromal period in Crohn's disease but not ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Epidemiology of IBS.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

A simple method for assessing intestinal inflammation in Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Role of faecal calprotectin as non-invasive marker of intestinal inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Faecal calprotectin: a new marker for Crohn's disease?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Faecal lactoferrin--a novel test to differentiate between the irritable and inflamed bowel?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Differing acute phase responses in Crohn's disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Fecal lactoferrin in discriminating inflammatory bowel disease from irritable bowel syndrome: a diagnostic meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Fecal assays detect hypersensitivity to cow's milk protein and gluten in adults with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Endothelial function and cardiovascular risk in active inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2015.6

21 January 2018

Lipid peroxidation markers in Crohn's disease: the associations and diagnostic value

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Fecal calprotectin in differential diagnosis of irritable bowel syndrome]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical utility of the assessment of fecal calprotectin in Leśniowski-Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accuracy of four fecal assays in the diagnosis of colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irritable bowel syndrome: toward a cost-effective management approach.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25732419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/AJG.2015.6

1 reference

Europe PubMed Central

2 September 2017

release_xqa4mu6aljacrasf7w4ut7ezdy

1 reference

https://api.fatcat.wiki/v0/release/xqa4mu6aljacrasf7w4ut7ezdy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38366860&oldid=1843754686"